Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis.
COVID-19
arrhythmia
cardiac magnetic resonance
infarction
myocarditis
Journal
Journal of clinical ultrasound : JCU
ISSN: 1097-0096
Titre abrégé: J Clin Ultrasound
Pays: United States
ID NLM: 0401663
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
revised:
24
11
2022
received:
16
10
2022
accepted:
28
11
2022
medline:
2
5
2023
pubmed:
23
12
2022
entrez:
22
12
2022
Statut:
ppublish
Résumé
Cardiac injury is commonly reported in COVID-19 patients, resulting associated to pre-existing cardiovascular disease, disease severity, and unfavorable outcome. Aim is to report cardiac magnetic resonance (CMR) findings in patients with myocarditis-like syndrome during the acute phase of SARS-CoV-2 infection (AMCovS) and post-acute phase (cPACS). Between September 2020 and January 2022, 39 consecutive patients (24 males, 58%) were referred to our department to perform a CMR for the suspicion of myocarditis related to AMCovS (n = 17) and cPACS (n = 22) at multimodality evaluation (clinical, laboratory, ECG, and echocardiography). CMR was performed for the assessment of volume, function, edema and fibrosis with standard sequences and mapping techniques. CMR diagnosis and the extension and amount of CMR alterations were recorded. Patients with suspected myocarditis in acute and post-COVID settings were mainly men (10 (59%) and 12 (54.5%), respectively) with older age in AMCovS (58 [48-64]) compared to cPACS (38 [26-53]). Myocarditis was confirmed by CMR in most of cases: 53% of AMCovS and 50% of cPACS with negligible LGE burden (3 [IQR, 1-5] % and 2 [IQR, 1-4] %, respectively). Myocardial infarction was identified in 4/17 (24%) patients with AMCovS. Cardiomyopathies were identified in 12% (3/17) and 27% (6/22) of patients with AMCovS and cPACS, including DCM, HCM and mitral valve prolapse. In patients with acute and post-acute COVID-19 related suspected myocarditis, CMR improves diagnostic accuracy characterizing ischemic and non-ischemic injury and unraveling subclinical cardiomyopathies.
Identifiants
pubmed: 36544331
doi: 10.1002/jcu.23416
pmc: PMC9878084
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
613-621Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 The Authors. Journal of Clinical Ultrasound published by Wiley Periodicals LLC.
Références
Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19. Circulation. 2020;142(1):68-78.
Scialo F, Daniele A, Amato F, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198(6):867-877.
Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905-919.
Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cell. 2020;9(11):2508.
Ranard LS, Fried JA, Abdalla M, et al. Approach to acute cardiovascular complications in COVID-19 infection. Circ Heart Fail. 2020;13(7):167-176.
Palmisano A, Gambardella M, D'Angelo T, et al. Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement. Clin Imaging. 2022;90:78-89.
Shi S, Qin M, Shen B, et al. Association of Cardiac Injury with Mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-810.
Sandoval Y, Januzzi JL, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244-1258.
Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution set Oversight Committee. J Am Coll Cardiol. 2022;79(17):1717-1756.
Karamitsos TD, Arvanitaki A, Karvounis H, Neubauer S, Ferreira VM. Myocardial tissue characterization and fibrosis by imaging. JACC Cardiovasc Imaging. 2020;13(5):1221-1234.
COVID-19 treatment guidelines.
Palmisano A, Benedetti G, Faletti R, et al. Early T1 myocardial MRI mapping: value in detecting myocardial hyperemia in acute myocarditis. Radiology. 2020;295(2):316-325.
Petersen SE, Friedrich MG, Leiner T, et al. Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc Imaging. 2022;15(4):685-699.
Cereda A, Toselli M, Palmisano A, et al. Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 registry. Hypertens Res. 2022;45(2):333-343.
Sticchi A, Cereda A, Toselli M, et al. Diabetes and mortality in patients with COVID-19: are we missing the link? Anatol J Cardiol. 2021;25(6):376-379.
Conte C, Esposito A, de Lorenzo R, et al. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: a post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021;31(7):2156-2164.
Agricola E, Beneduce A, Esposito A, et al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020;13(8):1792-1808.
Luetkens JA, Doerner J, Thomas DK, et al. Acute myocarditis: multiparametric cardiac MR imaging. Radiology. 2014;273(2):383-392.
Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330-2339.
Esposito A, Palmisano A, Natale L, et al. Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2462-2465.
Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861-1862.
Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827-3835.
Bois MC, Boire NA, Layman AJ, et al. COVID-19-associated nonocclusive fibrin microthrombi in the heart. Circulation. 2021;143(3):230-243.
Ardissino M, Nelson AJ, Maglietta G, et al. Sex-related differences in long-term outcomes after early-onset myocardial infarction. Front Cardiovasc Med. 2022;9:863811.
Talebi S, Jadhav P, Tamis-Holland JE. Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA): a review of the present and preview of the future. Curr Atheroscler Rep. 2021;23(9):49.
Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538.
Bonnemain J, Ltaief Z, Liaudet L. The right ventricle in COVID-19. J Clin Med. 2021;10(12):2535.
Loffi M, Regazzoni V, Toselli M, et al. Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: a multicenter Italian experience. PLoS One. 2021;16(1):e0245565.
Esposito A, Palmisano A, Toselli M, et al. Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy. Eur Radiol. 2021;31(6):4031-4041.
Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157-1172.
Omidi F, Hajikhani B, Kazemi SN, et al. COVID-19 and cardiomyopathy: a systematic review. Front Cardiovasc Med. 2021;8:695206.
Bertini M, D'aniello E, Cereda A, et al. The combination of chest computed tomography and standard electrocardiogram provides prognostic information and pathophysiological insights in COVID-19 pneumonia. J Clin Med. 2021;10(14):3031.
Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590.
Ingul CB, Grimsmo J, Mecinaj A, et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022;11(3):e023473.
Ståhlberg M, Reistam U, Fedorowski A, et al. Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. 2021;134(12):1451-1456.
Gyöngyösi M, Alcaide P, Asselbergs FW, et al. Long COVID and the cardiovascular system - elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC working groups on cellular biology of the heart and Myocardial & Pericardial Diseases. Cardiovasc Res. 2022:cvac115. doi:10.1093/cvr/cvac115
Peretto G, Villatore A, Rizzo S, et al. The Spectrum of COVID-19-associated myocarditis: a patient-tailored multidisciplinary approach. J Clin Med. 2021;10(9):1974.
Peretto G, de Luca G, Campochiaro C, et al. Telemedicine in myocarditis: evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic. Am Heart J. 2020;229:121-126.